Page 39 - BH-2-4
P. 39

Brain & Heart                                                             Neurologic manifestations of IBD



            14.  Zois CD, Katsanos KH, Kosmidou M, Tsianos EV.    retinal vascular complications of inflammatory bowel
               Neurologic manifestations in inflammatory bowel diseases:   disease. Ann Neurol. 1979;5(4):331-337.
               Current knowledge and novel insights.  J  Crohns Colitis.      doi: 10.1002/ana.410050405
               2010;4(2):115-124.
                                                               26.  Jackson  LM,  O’Gorman  PJ,  O’Connell  J,  Cronin  CC,
               doi: 10.1016/j.crohns.2009.10.005                  Cotter KP, Shanahan F. Thrombosis in inflammatory bowel
            15.  Babali A, Terzoudi A, Vadikolias K,  et al. Peripheral   disease: Clinical setting, procoagulant profile and factor V
               neuropathy electrophysiological screening in inflammatory   Leiden. QJM. 1997;90(3):183-188.
               bowel disease. Eur J Gastroenterol Hepatol. 2013;25(5):539-     doi: 10.1093/qjmed/90.3.183
               542.
                                                               27.  Goyal MK, Porwal YC, Gogna A, Gulati S. Splenic
               doi: 10.1097/MEG.0b013e32835ceca6                  infarct with scrub typhus: A rare presentation. Trop Doct.
            16.  Nemati R, Mehdizadeh S, Salimipour H, et al. Neurological   2019;50:234-236.
               manifestations related to Crohn’s disease: A  boon for the      doi: 10.1177/0049475519892092
               workforce. Gastroenterol Rep (Oxf). 2019;7(4):291-297.
                                                               28.  Cognat E, Crassard I, Denier C, Vahedi K, Bousser MG. Cerebral
               doi: 10.1093/gastro/gox034                         venous thrombosis in inflammatory bowel diseases: Eight cases
            17.  Wang Y, Kasper LH. The role of microbiome in central   and literature review. Int J Stroke. 2011;6(6):487-492.
               nervous system disorders. Brain Behav Immun. 2014;38:1-12.     doi: 10.1111/j.1747-4949.2011.00620.x
               doi: 10.1016/j.bbi.2013.12.015                  29.  Cho JM, Yang HR. Hair mineral and trace element contents as
            18.  Didesch MM, Averill A, Oh-Park M. Peripheral neuropathy   reliable markers of nutritional status compared to serum levels of
               after fecal microbiota transplantation for Clostridium difficile   these elements in children newly diagnosed with inflammatory
               infection: A case report. PM R. 2016;8(8):813-816.  bowel disease. Biol Trace Elem Res. 2018;185(1):20-29.
               doi: 10.1016/j.pmrj.2016.01.009                    doi: 10.1007/s12011-017-1225-6
            19.  Romijn JA, Corssmit EP, Havekes LM, Pijl H. Gut-brain axis.   30.  Casella G, Tontini GE, Bassotti G,  et al. Neurological
               Curr Opin Clin Nutr Metab Care. 2008;11(4):518-521.  disorders  and  inflammatory bowel diseases.  World J
                                                                  Gastroenterol. 2014;20(27):8764-8782
               doi: 10.1097/MCO.0b013e328302c9b0
                                                                  doi: 10.3748/wjg.v20.i27.8764
            20.  Spagnoli C, Pisani F, Di Mario F,  et al. Peripheral
               neuropathy  and  gastroenterologic  disorders:  An  overview   31.  Lee J, Hwang SW, Lee J, et al. A case of ulcerative colitis
               on an underrecognized association.  Acta Biomed.   presenting with cerebral venous thrombosis.  Intest Res.
               2018;89(Suppl 9):22-32.                            2018;16(2):306-311.
               doi: 10.23750/abm.v89i9-S.7956                     doi: 10.5217/ir.2018.16.2.306
            21.  Gondim FAA, Brannagan TH  3 , Sander  HW, Chin    RL,   32.  Karmiris K, Bossuyt P, Sorrentino D, et al. Cerebrovascular
                                       rd
               Latov  N. Peripheral  neuropathy  in patients  with   events in inflammatory bowel disease patients treated with
               inflammatory bowel disease. Brain. 2005;128(Pt 4):867-879.  anti-tumour necrosis factor alpha agents. J Crohns Colitis.
                                                                  2015;9(5):382-389.
               doi: 10.1093/brain/awh429
                                                                  doi: 10.1093/ecco-jcc/jjv042
            22.  Kim S, Kang SJ, Oh KW,  et al. Chronic inflammatory
               demyelinating polyneuropathy-like neuropathy as an initial   33.  Oldenburg B, Fijnheer R, van der Griend R, vanBerge-
               presentation of Crohn’s disease. BMC Neurol. 2015;15(1):48.  Henegouwen GP, Koningsberger JC. Homocysteine in
                                                                  inflammatory bowel disease: A risk factor for thromboembolic
               doi: 10.1186/s12883-015-0302-8                     complications? Am J Gastroenterol. 2000;95(10):2825-2830.
            23.  Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-     doi: 10.1111/j.1572-0241.2000.03193.x
               Biroulet L, Sandborn WJ. Natural history of adult ulcerative
               colitis in population-based cohorts: A  systematic review.   34.  Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel
               Clin Gastroenterol Hepatol. 2018;16(3):343-356.e3.  disease an independent and disease specific risk factor for
                                                                  thromboembolism? Gut. 2004;53(4):542-548.
               doi: 10.1016/j.cgh.2017.06.016
                                                                  doi: 10.1136/gut.2003.025411
            24.  Grainge MJ, West J, Card TR. Venous thromboembolism
               during active disease and remission in inflammatory bowel   35.  Stolz E, Klötzsch C, Schlachetzki F, Rahimi A. High-dose
                                                                  corticosteroid treatment is associated with an increased
               disease: A cohort study. Lancet. 2010;375(9715):657-663.
                                                                  risk of developing cerebral venous thrombosis. Eur Neurol.
               doi: 10.1016/S0140-6736(09)61963-2                 2003;49(4):247-248.
            25.  Schneiderman JH, Sharpe JA, Sutton DM. Cerebral and      doi: 10.1159/000070197


            Volume 2 Issue 4 (2024)                         10                               doi: 10.36922/bh.3486
   34   35   36   37   38   39   40   41   42   43   44